Nicholas Angelopoulos
Overview
Explore the profile of Nicholas Angelopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Livadas S, Angelopoulos N, Kollias A, Paparodis R, Androulakis I, Anagnostis P, et al.
J Endocrinol Invest
. 2025 Feb;
PMID: 39899246
Purpose: Levothyroxine (LT4) is commonly prescribed, but there is evidence strongly suggesting that a significant proportion of these patients are on treatment without solid evidence of hypothyroidism. Small trials on...
2.
Paparodis R, Bantouna D, Livadas S, Angelopoulos N
Curr Atheroscler Rep
. 2024 Dec;
27(1):21.
PMID: 39738779
Purpose Of Review: Atherosclerotic cardiovascular disease (ASCVD) is one of the most common causes of death globally and the leading one in the US. Elevated low-density lipoprotein (LDL) cholesterol is...
3.
Angelopoulos N, Iakovou I, Effraimidis G, Livadas S
Diagnostics (Basel)
. 2024 May;
14(9).
PMID: 38732360
(1) Background: After thyroid malignancy is ruled out, treatment options for multinodular goiter patients include surgery, levothyroxine suppressive therapy, and 131-I therapy. Surgery effectively reduces goiter size but carries risks...
4.
Paparodis R, Bantouna D, Karvounis E, Zoupas I, Livadas S, Angelopoulos N, et al.
Nutrients
. 2024 Jan;
16(1).
PMID: 38201941
Background: Vitamin D testing (VDT) and supplement use (VDS) are on the rise, but most patients remain deficient (<30 ng/mL-VDD). We designed the present real-world study to assess this paradox....
5.
Gitsi E, Livadas S, Angelopoulos N, Paparodis R, Raftopoulou M, Argyrakopoulou G
Nutrients
. 2023 Dec;
15(23).
PMID: 38068755
Achieving optimal glucose control in individuals with type 1 diabetes (T1DM) continues to pose a significant challenge. While continuous insulin infusion systems have shown promise as an alternative to conventional...
6.
Angelopoulos N, Paparodis R, Androulakis I, Anagnostis P, Boniakos A, Duntas L, et al.
Thyroid Res
. 2023 Jul;
16(1):18.
PMID: 37455308
Background: In the last decade, the combination of the widespread use of streptavidin-biotin technology and biotin-containing supplements (BCS) in the daily clinical practice, have led to numerous reports of erroneous...
7.
Angelopoulos N, Paparodis R, Androulakis I, Boniakos A, Argyrakopoulou G, Livadas S
Nutrients
. 2023 Jun;
15(12).
PMID: 37375586
Certain nutraceuticals, mainly containing red yeast rice, might be considered as an alternative therapy to statins in patients with dyslipidemia, although there is still insufficient evidence available with respect to...
8.
Livadas S, Bothou C, Kanaka-Gantenbein C, Chiotis D, Angelopoulos N, Macut D, et al.
Horm Metab Res
. 2020 Feb;
52(3):179-185.
PMID: 32074632
If circulating adrenal androgens levels rise before the age of 8 years in girls, this phenomenon is termed premature adrenarche (PA), while the concomitant appearance of pubic hair is called...
9.
Livadas S, Bothou C, Androulakis I, Boniakos A, Angelopoulos N, Duntas L
Thyroid
. 2019 Jul;
29(8):1169.
PMID: 31264526
No abstract available.
10.
Livadas S, Bothou C, Androulakis I, Boniakos A, Angelopoulos N, Duntas L
Thyroid
. 2018 Oct;
PMID: 30351232
Background: Levothyroxine (LT4) is one of the most prescribed drugs worldwide. Once started, approximately 90% of patients continue treatment long term. However, accumulating evidence suggests that many patients, for whom...